Glioblastoma Multiforme
Glioblastoma multiforme (GBM) is a highly aggressive brain tumor that arises from glial cells, leading to rapid growth and severe symptoms. It is known for its resistance to treatment and poor survival rates.
Glioblastoma: 131I-TLX101 Treatment Study
We are testing a new treatment combined with standard care for patients newly diagnosed with glioblastoma. The goal is to find a safe dose and understand how well it works.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Johannes Kepler University Linz
Neuroonkologisches Zentrum
Linz, Austria
Allgemeines Krankenhaus Der Stadt Wien Universitatskliniken
Klinische Abteilung für Onkologie
Vienna, Austria
Universitair Medisch Centrum Utrecht
Radiology
De Bilt, Netherlands
Sponsor: Telix Pharmaceuticals (Innovations) Pty Limited
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.